Prime Genomics
Latest round
- Series A
Last raised
- Jun 2019
Total raised
- $3.5M
Investors
- 1
About Prime Genomics
Prime Genomics Inc. develops advanced genomic solutions to enhance healthcare outcomes.Founded in 2010 and headquartered in Mountain View, US, Prime Genomics Inc. specializes in genomics and biotechnology. The company has undergone significant transformations since its inception, evolving its product offerings. Robert Weigle serves as the CEO.50 mn.Prime Genomics Inc. specializes in providing innovative genomic solutions tailored to the healthcare sector. Its flagship products include genomic testing and analysis services, designed to address the complex challenges faced by healthcare providers.The company generates revenue through a structured transaction model involving direct sales and subscription services for its genomic solutions. Clients pay a recurring fee for ongoing access to their services, alongside direct sales of flagship offerings.Prime Genomics Inc. The company is targeting expansion into European and Asian markets by 2023, aiming to broaden its geographical footprint.
Who invested in Prime Genomics
1 investor across 2 rounds
See all investors in Prime Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Prime Genomics
Who invested in Prime Genomics?
Prime Genomics has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Prime Genomics raised?
Prime Genomics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Prime Genomics last raise money?
Prime Genomics's most recent round on record is a Series A, in Jun 2019.
What does Prime Genomics do?
Prime Genomics is a biotechnology company.
Where is Prime Genomics headquartered?
Prime Genomics is headquartered in Mountain View, US.
Which VCs invest in companies like Prime Genomics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Prime Genomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Prime Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.